MX2016003122A - Metodo para tratar onicomicosis mediante hidroxipropil quitosano. - Google Patents

Metodo para tratar onicomicosis mediante hidroxipropil quitosano.

Info

Publication number
MX2016003122A
MX2016003122A MX2016003122A MX2016003122A MX2016003122A MX 2016003122 A MX2016003122 A MX 2016003122A MX 2016003122 A MX2016003122 A MX 2016003122A MX 2016003122 A MX2016003122 A MX 2016003122A MX 2016003122 A MX2016003122 A MX 2016003122A
Authority
MX
Mexico
Prior art keywords
hydroxypropyl chitosan
treat onychomycosis
onychomycosis
treat
administering
Prior art date
Application number
MX2016003122A
Other languages
English (en)
Inventor
Mailland Federico
Ceriani Daniela
Caserini Maurizio
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49118439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016003122(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MX2016003122A publication Critical patent/MX2016003122A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención está dirigida a un método para el tratamiento de onicomicosis mediante la administración tópica de una composición que contiene hidroxipropil quitosano como el único ingrediente activo y, en particular, mediante la administración de una composición tópica para las uñas que consiste esencialmente en: a) hidroxipropil quitosano, b) agua, c) al menos un alcanol inferior.
MX2016003122A 2013-09-10 2014-09-08 Metodo para tratar onicomicosis mediante hidroxipropil quitosano. MX2016003122A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13183789.0A EP2845597A1 (en) 2013-09-10 2013-09-10 Hydroxypropyl chitosan for the treatment of onychomycosis
PCT/EP2014/069099 WO2015036369A1 (en) 2013-09-10 2014-09-08 Method to treat onychomycosis by hydroxypropyl chitosan

Publications (1)

Publication Number Publication Date
MX2016003122A true MX2016003122A (es) 2016-11-14

Family

ID=49118439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003122A MX2016003122A (es) 2013-09-10 2014-09-08 Metodo para tratar onicomicosis mediante hidroxipropil quitosano.

Country Status (20)

Country Link
US (1) US20160213705A1 (es)
EP (2) EP2845597A1 (es)
JP (1) JP2016529326A (es)
KR (1) KR20160051751A (es)
CN (1) CN105579047A (es)
AU (1) AU2014320473A1 (es)
CA (1) CA2922236A1 (es)
CL (1) CL2016000542A1 (es)
CR (1) CR20160116A (es)
EA (1) EA201690551A1 (es)
HK (1) HK1223042A1 (es)
IL (1) IL244423A0 (es)
MA (1) MA38896A1 (es)
MD (1) MD20160039A2 (es)
MX (1) MX2016003122A (es)
PE (1) PE20160530A1 (es)
PH (1) PH12016500471A1 (es)
SG (1) SG11201601200SA (es)
TN (1) TN2016000054A1 (es)
WO (1) WO2015036369A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate

Also Published As

Publication number Publication date
KR20160051751A (ko) 2016-05-11
MD20160039A2 (ro) 2016-07-31
JP2016529326A (ja) 2016-09-23
PH12016500471A1 (en) 2016-05-16
CA2922236A1 (en) 2015-03-19
CL2016000542A1 (es) 2016-10-07
IL244423A0 (en) 2016-04-21
HK1223042A1 (zh) 2017-07-21
EP2845597A1 (en) 2015-03-11
AU2014320473A1 (en) 2016-03-24
WO2015036369A1 (en) 2015-03-19
EP3043804A1 (en) 2016-07-20
CN105579047A (zh) 2016-05-11
MA38896A1 (fr) 2018-03-30
SG11201601200SA (en) 2016-03-30
US20160213705A1 (en) 2016-07-28
TN2016000054A1 (en) 2017-07-05
PE20160530A1 (es) 2016-05-21
EA201690551A1 (ru) 2016-07-29
CR20160116A (es) 2016-06-14

Similar Documents

Publication Publication Date Title
CO2018001375A2 (es) Composiciones de retinoides tópicos
MY176814A (en) Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
MY193312A (en) Topical formulation for promoting wound healing
PH12015502405A1 (en) Methods and compositions for wound healing
FR2972924B1 (fr) Composition cosmetique et dermatologique et leurs utilisations
CY1121841T1 (el) Τοπικη αντιμυκητιασικη συνθεση για τη θεραπεια της ονυχομυκητιασης
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
PH12015501210A1 (en) Use of pidotimod to treat psoriasis
PH12016500471A1 (en) Method to treat onychomycosis by hydroxypropyl chitosan
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
FR2975003B1 (fr) Composition cosmetique topique presentant une penetration amelioree
UA81932U (ru) Комбинированный препарат "ротрин-дента" в виде геля для лечения воспалительных заболеваний слизистой оболочки полости рта
UA88421U (ru) Фармацевтическая композиция "фузипан-дерма" для лечения угревой болезни i-ii стадий
PL407256A1 (pl) Zastosowanie kompozycji i preparatu zawierających tioprolinę i kwas rozmarynowy, sposób spowalniania, przeciwdziałania, zapobiegania procesowi powstawania plam bielaczych skóry